Recurrent Pleural Effusion: Who Benefits from a Tunneled Pleural Catheter?

Abstract

Recurrent malignant pleural effusion (MPE) is a common concomitant phenomenon of malignant disease, which can worsen the patient's quality of life and lead to significant morbidity. Tunneled indwelling pleural catheters (TIPC) offer new modalities in patients with recurrent MPE and impaired dilatability of the lung. We report on our experience with 100 consecutive patients suffering from recurrent benign (n = 12) and malignant pleural effusion (n = 88) who were treated with TIPC. The catheter was placed during a VATS procedure or under local anesthesia in an open technique. The median residence time of the TIPC was 70 days; spontaneous pleurodesis was achieved in 29 patients. The rate of complications was low: pleura empyema (n = 4), accidental dislodgement (n = 2), malfunction of the drainage (n = 3). In conclusion, TIPC is a useful method for the palliative treatment of patients with recurrent malignant or nonmalignant pleural effusions and 3 groups of patients seem to benefit most: a) patients with the intraoperative finding of a trapped lung in diagnostic VATS procedure; b) patients after a history of repeated pleuracenteses or previously failed attempts at pleurodesis; c) patients in a reduced condition with a limited lifespan due to underlying disease.

Key words

tunneled pleural catheter - malignant pleural effusion - entrapped lung - pleurodesis - pleuracentesis

References

• 1 Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K. Prognostic value of pleural effusion in patients with non-small cell lung cancer.  Clin Cancer Res. 1997;  3 47-50
• 2 Aelony Y. Dry talc pleurodesis via chest tube.  Chest. 2003;  123 308
• 3 Viallat J R, Rey F, Astoul P, Boutin C. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases.  Chest. 1996;  110 1387-1393
• 4 Antonangelo L, Vargas F S, Teixeira L R, Acencio M M, Vaz M A, Filho M T, Marchi E. Pleurodesis induced by talc or silver nitrate: evaluation of collagen and elastic fibers in pleural remodeling.  Lung. 2006;  184 105-111
• 5 Robinson L A, Fleming W H, Galbraith T A. Intrapleural doxycycline control of malignant pleural effusions.  Ann Thorac Surg. 1993;  55 1115-1122
• 6 Ruckdeschel J C, Moores D, Lee J Y, Einhorn L H, Mandelbaum I, Koeller J, Weiss G R, Losada M, Keller J H. Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline.  Chest. 1991;  100 1528-1535
• 7 Dresler C M, Olak J, Herndon 2nd J E. Phase III intergroup study of talc poudrage vs. talc slurry sclerosis for malignant pleural effusion.  Chest. 2005;  127 909-915
• 8 Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review.  Eur J Cardiothorac Surg. 2006;  29 829-838
• 9 Froudarakis M E, Klimathianaki M, Pougounias M. Systemic inflammatory reaction after thoracoscopic talc poudrage.  Chest. 2006;  129 356-361
• 10 Maskell N A, Lee Y C, Gleeson F V, Hedley E L, Pengelly G, Davies R J. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size.  Am J Respir Crit Care Med. 2004;  170 377-382
• 11 Janssen J P. Is thoracoscopic talc pleurodesis really safe?.  Monaldi Arch Chest Dis. 2004;  61 35-38
• 12 Pien G W, Gant M J, Washam C L, Sterman D H. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion.  Chest. 2001;  119 1641-1646
• 13 Putnam Jr J B, Walsh G L, Swisher S G, Roth J A, Suell D M, Vaporciyan A A, Smythe W R, Merriman K W, DeFord L L. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter.  Ann Thorac Surg. 2000;  69 369-375
• 14 Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion.  Chest. 2006;  129 362-368
• 15 van den Toorn L M, Schaap E, Surmont V F, Pouw E M, van der Rijt K C, van Klaveren R J. Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter.  Lung Cancer. 2005;  50 123-127
• 16 Musani A I, Haas A R, Seijo L, Wilby M, Sterman D H. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters.  Respiration. 2004;  71 559-566
• 17 Pollak J S, Burdge C M, Rosenblatt M, Houston J P, Hwu W J, Murren J. Treatment of malignant pleural effusions with tunneled long-term drainage catheters.  J Vasc Interv Radiol. 2001;  12 201-208
• 18 Warren W H, Kalimi R, Khodadadian L M, Kim A W. Management of malignant pleural effusions using the pleur(x) catheter.  Ann Thorac Surg. 2008;  85 1049-1055
• 19 Tremblay A, Mason C, Michaud G. Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis.  Eur Respir J. 2007;  30 759-762
• 20 Janes S M, Rahman N M, Davies R J, Lee Y C. Catheter-tract metastases associated with chronic indwelling pleural catheters.  Chest. 2007;  131 1232-1234